|
Symbol Name ID |
Pip4k2b
phosphatidylinositol-5-phosphate 4-kinase, type II, beta MGI:1934234 |
Excel File
| Allelic Composition Genetic Background |
Annotated Term | Reference |
| Pip4k2bGt(Betageo)1Lca/Pip4k2bGt(Betageo)1Lca involves: 129S/SvEv * C57BL/6 |
abnormal circulating insulin level | J:91023 |
| abnormal vertebral spinous process morphology | J:91023 | |
| decreased body weight | J:91023 | |
| decreased bone mineral density | J:91023 | |
| decreased total body fat amount | J:91023 | |
| increased insulin sensitivity | J:91023 | |
| perinatal lethality, incomplete penetrance | J:91023 | |
| short femur | J:91023 | |
| Pip4k2bGt(OST341064)Lex/Pip4k2bGt(OST341064)Lex involves: 129S5/SvEvBrd * C57BL/6J |
decreased percent body fat/body weight | J:185494 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/17/2024 MGI 6.24 |
|
|
|
||
Analysis Tools